Literature DB >> 7199692

Activity changes in rats following acute trimethyltin exposure.

H S Swartzwelder, R S Dyer, W Holahan, R D Myers.   

Abstract

The aliphatic organo-metal derivative, trimethyltin, causes marked morphological damage to the central nervous system (CNS), when the compound is administered by the intragastric route. This report describes certain behavioral consequences of [CH3]3Sn treatment. Either 7.0 mg/kg [CH3]3SnCl or 0.9% saline was injected intragastrically in male rats of Long-Evans strain divided into two equal groups of nine each. Forty days later open-field activity during a 2-min interval was measured for each rat. Following activity testing, the animals were trained to press a lever for food reinforcement on an ascending fixed-ratio series ranging from FR 2 to FR 99. The results showed that rats treated with [CH3]3SnCl were three times as active as controls in the open field, and emitted lever responses at a significantly higher rate than controls throughout the fixed-ratio series regardless of the reinforcement schedule. The possible neuropathological consequences and the relative permanence of the neurobehavioral changes following tin treatment are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7199692

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  9 in total

1.  Blockade of glutamatergic and GABAergic receptor channels by trimethyltin chloride.

Authors:  Katharina Krüger; Victoria Diepgrond; Maria Ahnefeld; Christina Wackerbeck; Michael Madeja; Norbert Binding; Ulrich Musshoff
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

2.  Acute treatment with trimethyltin alters alcohol self-selection.

Authors:  R D Myers; H S Swartzwelder; R S Dyer
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

3.  Standardized Herbal Formula PM012 Decreases Cognitive Impairment and Promotes Neurogenesis in the 3xTg AD Mouse Model of Alzheimer's Disease.

Authors:  Minsook Ye; Hwan-Suck Chung; Yong Ho An; Su-Jin Lim; Won Choi; A Ram Yu; Jin Su Kim; Manho Kang; Seunghun Cho; Insop Shim; Hyunsu Bae
Journal:  Mol Neurobiol       Date:  2015-10-07       Impact factor: 5.590

4.  Selective learning impairment of delayed reinforcement autoshaped behavior caused by low doses of trimethyltin.

Authors:  C A Cohen; R B Messing; S B Sparber
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Neuroprotective Effect of Lucium chinense Fruit on Trimethyltin-Induced Learning and Memory Deficits in the Rats.

Authors:  Hyun-Jung Park; Hyun Soo Shim; Woong Ki Choi; Kyung Soo Kim; Hyunsu Bae; Insop Shim
Journal:  Exp Neurobiol       Date:  2011-09-20       Impact factor: 3.261

6.  Chronic Treatment with Squid Phosphatidylserine Activates Glucose Uptake and Ameliorates TMT-Induced Cognitive Deficit in Rats via Activation of Cholinergic Systems.

Authors:  Hyun-Jung Park; Seung Youn Lee; Hyun Soo Shim; Jin Su Kim; Kyung Soo Kim; Insop Shim
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-22       Impact factor: 2.629

7.  The neuroprotective effect of gugijihwang-tang on trimethyltin-induced memory dysfunction in the rat.

Authors:  Eun-Yee Jung; Mi-Sook Lee; Chang Joon Ahn; Seung-Hun Cho; Hyunsu Bae; Insop Shim
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-04       Impact factor: 2.629

8.  Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer's disease.

Authors:  Minsook Ye; Hwan-Suck Chung; Chanju Lee; Moon Sik Yoon; A Ram Yu; Jin Su Kim; Deok-Sang Hwang; Insop Shim; Hyunsu Bae
Journal:  J Neuroinflammation       Date:  2016-01-16       Impact factor: 8.322

9.  Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model.

Authors:  Hyunjung Baek; Minsook Ye; Geun-Hyung Kang; Chanju Lee; Gihyun Lee; Da Bin Choi; Jaehoon Jung; Hyunseong Kim; Seonhwa Lee; Jin Su Kim; Hyun-Ju Lee; Insop Shim; Jun-Ho Lee; Hyunsu Bae
Journal:  Oncotarget       Date:  2016-10-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.